Loading clinical trials...

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy | Clinical Trials | Clareo Health

COMPLETEDNA

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy

NCT03200769•University Hospital, Lille

View on ClinicalTrials.gov

Summary

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy. The primary goal is to evaluate the efficacity after 3 months of obstructive sleep apnea syndrome treatment by CPAP on the epilepsy seizures frequency.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Male or female age ≥ 18.
•Patient suffering of pharmacoresistant epilepsy.
•Frequency of epilepsy crisis : minimum 4 per month.
•Antiepileptic drug on a stable dose for at least 2 months.
•SA-SDQ score ≥ 25.
•Written informed consent obtained.
•Patient affiliated with a social security regimen.

Exclusion Criteria

•Pregnant females (female subjects who are lactating are not excluded).
•Anterior CPAP treatment.
•Central apnea \>20% during the initial polysomnography.
•Mental retardation or severe cognitive impairment.
•Presence of pseudo-crisis.

Locations (1)

CHRU de Lille - Rue Emile LAINE - Hopitâl Roger Salengro Rez de Chaussée - Neurophysiologie Clinique

Lille, France

Key Dates

Start Date

July 21, 2014

Primary Completion Date

July 1, 2021

Completion Date

July 1, 2021

Last Updated

September 30, 2022

Enrollment

103

ACTUAL participants

Conditions

Sleep Apnea SyndromesEpilepsies, Partial

Interventions

CPAP active

DEVICE

CPAP placebo

DEVICE

Apnea, Stroke and Incident Cardiovascular Events

NCT04399200

StrokeSleep-disordered Breathing+4 more

View study

ENROLLING_BY_INVITATIONNA

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

NCT07169058

Obstructive Sleep Apnea Syndromes

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 30, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of the Efficacy of the Treatment of Sleep Apnea Syndrome by CPAP in Pharmacoresistant Epilepsy

Inclusion Criteria

Exclusion Criteria

Apnea, Stroke and Incident Cardiovascular Events

Fascial Mobilization Along the Vagus Nerve and Its Effects on Acute Physiological Parameters in Obstructive Sleep Apnea

Adverse Long-term Consequences of Sleep Disordered Breathing: The Ottawa Hospital (TOH) Sleep Database

Janus Feasibility Study

Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies

Evaluation of An Optical Measurement Algorithm Combined With Patient and Provider Input to Reduce Mask Exchanges During Initial Positive Airway Pressure Therapy